| HOME >> BIOLOGY >> TECHNOLOGY |
2007 2006
ASSETS (Note 1)
Current assets:
Cash and cash equivalents $18,553 $8,263
Short-term investments 10,933 22,867
Accounts receivable, net 8,694 6,849
Prepaid expenses 1,055 1,234
Inventory 1,184 961
Other current assets 248 378
Total current assets 40,667 40,552
Property and equipment, net 7,388 7,463
Goodwill 9,927 9,927
Deferred costs 5,236 1,783
Other assets 749 1,120
Total assets $63,967 $60,845
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $1,864 $1,271
Accrued compensation 2,712 2,258
Accrued liabilities 4,458 4,720
Current portion of restructuring
costs 610 1,128
Deferred revenue, current portion 1,140 404
Current portion of loans payable and
capital lease obligations 4,721 6,355
Contingent value rights 2,102 2,813
Total current liabilities 17,607 18,949
Long-term 3% convertible promissory note 20,683 25,000
Long-term 0% convertible promissory note 18,168
'/>"/>
| SOURCE Monogram Biosciences, Inc. Copyright©2007 PR Newswire. All rights reserved |